The common warts market is expected to reach a significant value of US$ 1,100 million by 2033, with a compound annual growth rate of 3.6% | FMI study

Market for common warts

The fight against common warts is gaining momentum. The common warts market is expected to reach a value of 1.1 billion US dollars by 2033According to a new report by Future Market Insights (FMI), this forecast reflects a steady growth trend with a CAGR (compound annual growth rate) from 3.6% from 2023 to 2033.

Furthermore, the recurrence of the disease after surgery and therapy can be exploited to develop a permanent treatment for warts. In addition, the market is influenced by a high number of acquisition strategies and corporate alliances to develop novel therapies, as well as an increase in investments in research and development. Each form of warts is associated with a separate and specific HPV, which can be created by identifying and developing a customized vaccination against the virus. Due to the introduction of novel treatment alternatives, the North American market is expected to account for the largest revenue share during the forecast period.

Get a sample copy of the report:
https://www.futuremarketinsights.com/reports/sample/rep-gb-16204

Furthermore, increased healthcare expenditure along with availability of treatment options would accelerate the market development in this area. Moreover, increased awareness about the disease has led to expansion of the industry. These factors are expected to boost the revenue growth in the common warts market in the region throughout the forecast period.

Key insights into the common warts market:

• FMI forecasts the global common warts market to grow by 3.6% Value CAGR until 2033
• The global market for common warts is estimated to have a market value of 770 million US dollars
• The global common warts market is expected to reach a market value of 1100 million US dollars
• According to Future Market Insights, the Asia-Pacific region is expected to grow by CAGR of 3% in the assessment period 2023–2033.
• In North America, growth of CAGR of 3.5% in the assessment period 2023–2033.
• In Europe, growth of CAGR of 3.3% in the assessment period 2023–2033.
• The salicylic acid segment is expected to hold the largest market share in common warts during the forecast period 2023-2033.

“In 2021, North America accounted for the largest market share in the global common warts market. During the forecast period, this trend is expected to continue. Increasing knowledge about numerous treatment options along with the introduction of new drugs in this field are expected to drive the growth of the common warts market in North America,” says an analyst at FMI.

Leverage tailored insights: Customize your report for maximum impact:
https://www.futuremarketinsights.com/customization-available/rep-gb-16204

Competition in the common warts market

Major players in the common warts market are Nielsen BioSciences, Verrica Pharmaceutical, Aclaris Therapeutics, Inc., KinoPharma, Inc., pHion Therapeutics, Orgenesis, Novan, Cassopeia Pharmaceuticals, Innovax and Torii Pharmaceutical Co. Ltd.

• In March 2020, Verrica Pharmaceuticals Inc. and Torii Pharmaceutical Co., Ltd. announced a collaboration and license agreement to develop and sell product candidates, including VP-102, a topical formulation of cantharidin for the treatment of molluscum contagiosum and common warts in Japan.

Key segments:

Common Warts Market by Diagnosis:

Common Warts Market by Drug Type:

• Imiquimod
• Silver nitrate
• Glutaraldehyd
• Salicylic acid
• formaldehyde
• Aminolevulinic acid

Common Warts Market by Drug Class:

• Topical retinoids
• Oral retinoids

Author of:

Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) has over 12 years of experience in healthcare, medical device and pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.

Identifying clients’ key challenges and developing robust, hypothesis-based solutions that give them strategic decision-making authority comes naturally to him. His main skills lie in areas such as market entry and expansion strategies, feasibility studies, competitive analysis and strategic transformation.

Sabyasachi holds a degree in microbiology and is the author of numerous publications and has been cited in peer-reviewed journals including The Journal of mHealth, ITN Online and Spinal Surgery News.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, Stevie Award recipient and member of the Greater New York Chamber of Commerce) provides in-depth insights into the driving factors that are driving demand in the market. FMI is the world’s leading provider of market intelligence, advisory services, consulting and events for the packaging, food and beverage, consumer technology, healthcare, industrial and chemical markets. With a team of over 5000 analysts worldwide, FMI offers global, regional and local expertise on various sectors and industry trends in more than 110 countries.

Contact us:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
Phone: +1-845-579-5705
For sales inquiries: [email protected]
Website: https://www.futuremarketinsights.com
LinkedIn| Þjórsárden| Blog | YouTube